Table 4.
Compositions of directly compressible tablet formulations containing l-carnitine base microcapsules.
Trial | Formulation | quantity (mg) | MCC PH 112 (mg) | AcDiSol (mg) | Mg stearate (mg) | Tablet weight (mg) |
---|---|---|---|---|---|---|
C1 | F10 | 445.5 | 484.5 | 50 | 20 | 1000 |
C2 | F4 | 473 | 457 | 50 | 20 | 1000 |
C3 | F11 | 528 | 402 | 50 | 20 | 1000 |
C4 | F12 | 693 | 237 | 50 | 20 | 1000 |
C5 | F13 | 445.5 | 484.5 | 50 | 20 | 1000 |
C6 | F14 | 473 | 457 | 50 | 20 | 1000 |
C7 | F15 | 528 | 402 | 50 | 20 | 1000 |
C8 | F16 | 693 | 237 | 50 | 20 | 1000 |